Quay lại
Giá Kintor Pharmaceutical Limited (09939.HK)
Biểu đồ giá cổ phiếu 09939.HK
KINTOR PHARMA-B (09939.HK)
Kintor Pharmaceutical Limited
HK$2.35
0.85%
$0.02
Thị trường chính thức: Jan 19, 15:02:25 HKT
Thống kê chính
Giá đóng cửa trước
$2.33
Giá mở cửa
$2.33
Phạm vi ngày
$2.29 - $2.38
Phạm vi 52 tuần
$0.85 - $3.1
Khối lượng
1.6M
Khối lượng trung bình
1.5M
EPS (TTM)
-0.42
Tỷ suất cổ tức
--
Vốn hóa thị trường
$1.1B
KINTOR PHARMA-B là gì?
Kintor Pharmaceutical Ltd. is a clinical-stage novel drug developer in China, which engages in the proprietary research and development of innovative medicine products for cancers and other Androgen receptor-related diseases. The company is headquartered in Suzhou, Jiangsu and currently employs 136 full-time employees. The company went IPO on 2020-05-22. The firm's products are dedicated to addressing disease areas that have not met clinical needs, and its pipeline mainly covers indications of dermatology (such as androgenetic alopecia, acne vulgaris) and indications of tumors. The firm has two core drugs in the dermatology field, KX-826 and GT20029. The firm's other disease areas include metastatic castration-resistant prostate cancer (mCRPC), liver cancer, idiopathic pulmonary fibrosis, malignant blood diseases and various solid tumors.
Đặc điểm
Chiến lược giao dịch
Tài nguyên
© 2025 Finture Development Limited. All rights reserved
